Total Payments
$893,165
2024 Payments
$138,990
Companies
29
Transactions
1,214
Medicare Patients
431
Medicare Billing
$116,684
Payment Breakdown by Category
Other$686,941 (76.9%)
Travel$117,967 (13.2%)
Consulting$59,014 (6.6%)
Food & Beverage$29,085 (3.3%)
Education$157.50 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $590,968 | 321 | 66.2% |
| Travel and Lodging | $117,967 | 463 | 13.2% |
| Consulting Fee | $59,014 | 27 | 6.6% |
| Compensation for serving as faculty or as a speaker for a medical education program | $48,400 | 14 | 5.4% |
| Honoraria | $41,073 | 21 | 4.6% |
| Food and Beverage | $29,085 | 358 | 3.3% |
| Compensation for serving as faculty or as a speaker for a non-accredited and noncertified continuing education program | $6,500 | 8 | 0.7% |
| Education | $157.50 | 2 | 0.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Allergan, Inc. | $244,349 | 409 | $0 (2022) |
| Merck Sharp & Dohme LLC | $226,438 | 310 | $0 (2024) |
| ABBVIE INC. | $207,533 | 228 | $0 (2024) |
| Shionogi Inc | $80,707 | 90 | $0 (2024) |
| AIMMUNE THERAPEUTICS, INC. | $37,391 | 17 | $0 (2024) |
| La Jolla Pharmaceutical Company | $29,233 | 38 | $0 (2024) |
| SANOFI PASTEUR INC. | $24,741 | 24 | $0 (2022) |
| TETRAPHASE PHARMACEUTICALS, INC. | $22,963 | 23 | $0 (2020) |
| Melinta Therapeutics, LLC | $10,280 | 25 | $0 (2022) |
| Theravance Biopharma Inc. | $5,430 | 14 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $138,990 | 107 | ABBVIE INC. ($49,603) |
| 2023 | $119,625 | 145 | AbbVie Inc. ($91,966) |
| 2022 | $87,034 | 125 | ABBVIE INC. ($35,424) |
| 2021 | $53,874 | 69 | AbbVie Inc. ($30,539) |
| 2020 | $76,409 | 109 | Allergan, Inc. ($27,705) |
| 2019 | $185,992 | 280 | Allergan Inc. ($92,813) |
| 2018 | $172,801 | 270 | Allergan Inc. ($108,724) |
| 2017 | $58,440 | 109 | Merck Sharp & Dohme Corporation ($37,947) |
All Payment Transactions
1,214 individual payment records from CMS Open Payments — Page 1 of 49
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/30/2024 | ABBVIE INC. | AVYCAZ (Drug) | Consulting Fee | Cash or cash equivalent | $600.00 | General |
| Category: ANTI-INFECTIVE | ||||||
| 12/24/2024 | ABBVIE INC. | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,425.00 | General |
| 12/08/2024 | Shionogi Inc | Fetroja (Drug) | Travel and Lodging | Cash or cash equivalent | $122.22 | General |
| Category: Infections and Infectious Diseases | ||||||
| 12/08/2024 | Shionogi Inc | Fetroja (Drug) | Travel and Lodging | Cash or cash equivalent | $34.95 | General |
| Category: Infections and Infectious Diseases | ||||||
| 12/08/2024 | Shionogi Inc | Fetroja (Drug) | Travel and Lodging | Cash or cash equivalent | $21.96 | General |
| Category: Infections and Infectious Diseases | ||||||
| 12/08/2024 | Shionogi Inc | Fetroja (Drug) | Travel and Lodging | Cash or cash equivalent | $19.91 | General |
| Category: Infections and Infectious Diseases | ||||||
| 12/06/2024 | La Jolla Pharmaceutical Company | XACDURO (Drug) | Food and Beverage | In-kind items and services | $138.14 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 12/05/2024 | GENZYME CORPORATION | XENPOZYME (Biological) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: Genetic Disease | ||||||
| 12/04/2024 | ABBVIE INC. | — | Food and Beverage | In-kind items and services | $0.03 | General |
| 11/19/2024 | ABBVIE INC. | AVYCAZ (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $712.50 | General |
| Category: ANTI-INFECTIVE | ||||||
| 11/14/2024 | Shionogi Inc | Fetroja (Drug) | Compensation for serving as faculty or as a speaker for a medical education program | Cash or cash equivalent | $4,860.00 | General |
| Category: Infections and Infectious Diseases | ||||||
| 11/13/2024 | Shionogi Inc | Fetroja (Drug) | Travel and Lodging | Cash or cash equivalent | $205.19 | General |
| Category: Infections and Infectious Diseases | ||||||
| 11/13/2024 | Shionogi Inc | Fetroja (Drug) | Travel and Lodging | Cash or cash equivalent | $189.36 | General |
| Category: Infections and Infectious Diseases | ||||||
| 11/13/2024 | Shionogi Inc | Fetroja (Drug) | Food and Beverage | In-kind items and services | $110.73 | General |
| Category: Infections and Infectious Diseases | ||||||
| 11/06/2024 | iRhythm Technologies, Inc. | ZIO XT Patch (Device), Zio monitor | Food and Beverage | In-kind items and services | $29.60 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 11/06/2024 | ABBVIE INC. | AVYCAZ (Drug) | Food and Beverage | In-kind items and services | $0.01 | General |
| Category: ANTI-INFECTIVE | ||||||
| 10/29/2024 | ABBVIE INC. | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,375.00 | General |
| 10/29/2024 | AIMMUNE THERAPEUTICS, INC. | ZENPEP (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $750.00 | General |
| Category: ENDOCRINE PANCREATIC INSUFFICIENCY | ||||||
| 10/29/2024 | AIMMUNE THERAPEUTICS, INC. | ZENPEP (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $750.00 | General |
| Category: ENDOCRINE PANCREATIC INSUFFICIENCY | ||||||
| 10/22/2024 | ABBVIE INC. | AVYCAZ (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,325.00 | General |
| Category: ANTI-INFECTIVE | ||||||
| 10/10/2024 | ABBVIE INC. | — | Food and Beverage | In-kind items and services | $125.00 | General |
| 10/01/2024 | ABBVIE INC. | AVYCAZ (Drug) | Travel and Lodging | In-kind items and services | $483.61 | General |
| Category: ANTI-INFECTIVE | ||||||
| 10/01/2024 | ABBVIE INC. | — | Travel and Lodging | In-kind items and services | $399.80 | General |
| 10/01/2024 | ABBVIE INC. | AVYCAZ (Drug) | Travel and Lodging | In-kind items and services | $294.69 | General |
| Category: ANTI-INFECTIVE | ||||||
| 10/01/2024 | ABBVIE INC. | AVYCAZ (Drug) | Travel and Lodging | In-kind items and services | $47.63 | General |
| Category: ANTI-INFECTIVE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 3 | 75 | 120 | $40,130 | $16,095 |
| 2022 | 4 | 93 | 178 | $63,980 | $25,245 |
| 2021 | 5 | 115 | 202 | $80,025 | $31,969 |
| 2020 | 4 | 148 | 253 | $108,440 | $43,375 |
Total Patients
431
Total Services
753
Medicare Billing
$116,684
Procedure Codes
16
All Medicare Procedures & Services
16 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99291 | Critical care, first 30-74 minutes | Facility | 2023 | 38 | 52 | $26,260 | $10,054 | 38.3% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 18 | 33 | $7,920 | $3,585 | 45.3% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 19 | 35 | $5,950 | $2,457 | 41.3% |
| 99291 | Critical care, first 30-74 minutes | Facility | 2022 | 50 | 90 | $45,450 | $18,130 | 39.9% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 19 | 44 | $10,560 | $4,021 | 38.1% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 13 | 30 | $5,100 | $1,930 | 37.9% |
| 36556 | Insertion of non-tunneled central venous tube for infusion (5 years or older) | Facility | 2022 | 11 | 14 | $2,870 | $1,163 | 40.5% |
| 99291 | Critical care delivery critically ill or injured patient, first 30-74 minutes | Facility | 2021 | 63 | 116 | $60,860 | $24,289 | 39.9% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 18 | 45 | $10,800 | $4,363 | 40.4% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 12 | 17 | $2,890 | $1,149 | 39.8% |
| 36556 | Insertion of central venous catheter for infusion, patient 5 years or older, not tunneled | Facility | 2021 | 11 | 13 | $2,790 | $1,092 | 39.1% |
| 99221 | Initial hospital inpatient care, typically 30 minutes per day | Facility | 2021 | 11 | 11 | $2,685 | $1,076 | 40.1% |
| 99291 | Critical care delivery critically ill or injured patient, first 30-74 minutes | Facility | 2020 | 91 | 167 | $86,840 | $34,963 | 40.3% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2020 | 28 | 56 | $13,440 | $5,435 | 40.4% |
| 36556 | Insertion of central venous catheter for infusion, patient 5 years or older | Facility | 2020 | 17 | 18 | $4,320 | $1,526 | 35.3% |
| 99222 | Initial hospital inpatient care, typically 50 minutes per day | Facility | 2020 | 12 | 12 | $3,840 | $1,452 | 37.8% |
About Dr. Joshua Rosenberg, M.D
Dr. Joshua Rosenberg, M.D is a Critical Care Medicine healthcare provider based in Brooklyn, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 09/20/2007. The National Provider Identifier (NPI) number assigned to this provider is 1629264924.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Joshua Rosenberg, M.D has received a total of $893,165 in payments from pharmaceutical and medical device companies, with $138,990 received in 2024. These payments were reported across 1,214 transactions from 29 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($590,968).
As a Medicare-enrolled provider, Rosenberg has provided services to 431 Medicare beneficiaries, totaling 753 services with total Medicare billing of $116,684. Data is available for 4 years (2020–2023), covering 16 distinct procedure/service records.
Ad
Practice Information
- Specialty Critical Care Medicine
- Other Specialties Infectious Disease
- Location Brooklyn, NY
- Active Since 09/20/2007
- Last Updated 11/10/2011
- Taxonomy Code 207RC0200X
- Entity Type Individual
- NPI Number 1629264924
Products in Payments
- AVYCAZ (Drug) $321,258
- ZERBAXA (Drug) $149,235
- Fetroja (Drug) $63,898
- RECARBRIO (Drug) $43,308
- DALVANCE (Drug) $42,570
- ZENPEP (Drug) $37,391
- XERAVA (Drug) $36,533
- TEFLARO (Drug) $32,438
- Xerava (Drug) $12,890
- FLUZONE HIGH-DOSE (Biological) $10,824
- Baxdela (Drug) $9,565
- VIBATIV (Drug) $5,430
- ADACEL (Biological) $5,220
- FLUBLOK QUADRIVALENT NORTHERN HEMISPHERE (Biological) $4,003
- XACDURO (Drug) $2,406
- DISEASE STATE (Drug) $1,664
- NUZYRA (Drug) $1,031
- FLUZONE QUADRIVALENT (Biological) $870.00
- ELIQUIS (Drug) $549.88
- Vabomere (Drug) $545.40
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Critical Care Medicine Doctors in Brooklyn
Dr. Aaliya Burza, M.d, M.D
Critical Care Medicine — Payments: $54,441
Critical Care Medicine $54,441
Dr. Keerthana Keshava, M.b.b.s, M.B.B.S
Critical Care Medicine — Payments: $23,722
Critical Care Medicine $23,722
Dr. Yizhak Kupfer, Md, MD
Critical Care Medicine — Payments: $22,120
Critical Care Medicine $22,120
Mediha Ibrahim, M.d, M.D
Critical Care Medicine — Payments: $14,961
Critical Care Medicine $14,961
Igor Chernyavskiy, M.d, M.D
Critical Care Medicine — Payments: $7,598
Critical Care Medicine $7,598
Chetana Pendkar, M.b.b.s, M.B.B.S
Critical Care Medicine — Payments: $6,717
Critical Care Medicine $6,717